Iota-carrageenan/xylometazoline nasal spray - Marinomed
Alternative Names: Carravin; MAM-2001-1; Xylometazoline/iota-carrageenan nasal spray- MarinomedLatest Information Update: 08 Oct 2025
At a glance
- Originator Marinomed Biotechnologie
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Viral envelope protein inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Nasal congestion
Most Recent Events
- 12 Dec 2024 Preregistration for Nasal congestion (Intranasal) (Marinomed Biotechnologie pipeline; December 2024)